Skip to main content
Top
Published in: International Urology and Nephrology 12/2023

19-04-2023 | Respiratory Microbiota | Nephrology - Original Paper

Global trends and hotspots in IgA nephropathy: a bibliometric analysis and knowledge map visualization from 2012 to 2023

Authors: Jingyu Wang, Xin Wang, Xintian Cai, Dikang Pan

Published in: International Urology and Nephrology | Issue 12/2023

Login to get access

Abstract

Objectives

This study aimed to investigate the distribution patterns and research frontiers of international literature and thus present a holistic bibliometric evaluation of the studies on IgA nephropathy.

Methods

The Web of Science Core Collection database was searched for studies of IgA nephropathy from January 2012 to March 2023. The keywords and references are analyzed by CiteSpace, while the countries and institutions are analyzed by VOSviewer.

Results

A total of 2987 publications on IgA nephropathy were included. The country with the most publications was China (n = 1299), and the institution with the most publications was Peking University (n = 139). The most frequent keywords were IgA nephropathy (n = 2013), Oxford classification (n = 482), and diseases (n = 433). The keywords that continue to burst out at high intensity are multicenter study and gut microbiota. Moreover, the top five references for burst strength were also listed.

Conclusions

IgA nephropathy has attracted widespread research interest, particularly in high-prevalence areas. From 2012 to 2023, publications on IgA nephropathy show a linear increase. China is the country with the highest number of publications and Peking University is the institution with the highest number of publications. Current research hotspots and frontiers are mainly multicenter studies related to IgA nephropathy and its exploration with gut microbiota. Overall, we have provided a comprehensive scientometric analysis of IgA nephropathy that will inform researchers and healthcare practitioners.
Appendix
Available only for authorised users
Literature
1.
go back to reference O’Shaughnessy MM, Hogan SL, Thompson BD, Coppo R, Fogo AB, Jennette JC (2018) Glomerular disease frequencies by race, sex and region: results from the International Kidney Biopsy Survey. Nephrol Dial Transpl 33(4):661–669CrossRef O’Shaughnessy MM, Hogan SL, Thompson BD, Coppo R, Fogo AB, Jennette JC (2018) Glomerular disease frequencies by race, sex and region: results from the International Kidney Biopsy Survey. Nephrol Dial Transpl 33(4):661–669CrossRef
4.
go back to reference Suzuki H, Kiryluk K, Novak J, Moldoveanu Z, Herr AB, Renfrow MB et al (2011) The pathophysiology of IgA nephropathy. J Am Soc Nephrol 22(10):1795–1803CrossRefPubMedPubMedCentral Suzuki H, Kiryluk K, Novak J, Moldoveanu Z, Herr AB, Renfrow MB et al (2011) The pathophysiology of IgA nephropathy. J Am Soc Nephrol 22(10):1795–1803CrossRefPubMedPubMedCentral
5.
go back to reference Rovin BH, Adler SG, Barratt J, Bridoux F, Burdge KA, Chan TM et al (2021) Executive summary of the KDIGO 2021 guideline for the management of glomerular diseases. Kidney Int 100(4):753–779CrossRefPubMed Rovin BH, Adler SG, Barratt J, Bridoux F, Burdge KA, Chan TM et al (2021) Executive summary of the KDIGO 2021 guideline for the management of glomerular diseases. Kidney Int 100(4):753–779CrossRefPubMed
6.
go back to reference Mou J, Cui Y, Kurcz K (2019) Bibliometric and visualized analysis of research on major e-commerce journals using Citespace. J Electron Commer Re 20(4):219–237 Mou J, Cui Y, Kurcz K (2019) Bibliometric and visualized analysis of research on major e-commerce journals using Citespace. J Electron Commer Re 20(4):219–237
7.
go back to reference Diem A, Wolter SC (2013) The use of bibliometrics to measure research performance in education sciences. Res High Educ 54(1):86–114CrossRef Diem A, Wolter SC (2013) The use of bibliometrics to measure research performance in education sciences. Res High Educ 54(1):86–114CrossRef
8.
go back to reference Mayr P, Scharnhorst A (2015) Scientometrics and information retrieval: weak-links revitalized. Scientometrics 102(3):2193–2199CrossRef Mayr P, Scharnhorst A (2015) Scientometrics and information retrieval: weak-links revitalized. Scientometrics 102(3):2193–2199CrossRef
9.
go back to reference Abramo G, D’Angelo CA, Viel F (2011) The field standardized average impact of national research systems compared to world average: the case of Italy. Scientometrics 88(2):599–615CrossRef Abramo G, D’Angelo CA, Viel F (2011) The field standardized average impact of national research systems compared to world average: the case of Italy. Scientometrics 88(2):599–615CrossRef
10.
go back to reference Wu H, Wang Y, Tong L, Yan H, Sun Z (2021) Global research trends of ferroptosis: a rapidly evolving field with enormous potential. Front Cell Dev Biol 9:646311CrossRefPubMedPubMedCentral Wu H, Wang Y, Tong L, Yan H, Sun Z (2021) Global research trends of ferroptosis: a rapidly evolving field with enormous potential. Front Cell Dev Biol 9:646311CrossRefPubMedPubMedCentral
11.
go back to reference Wu H, Li Y, Tong L, Wang Y, Sun Z (2021) Worldwide research tendency and hotspots on hip fracture: a 20-year bibliometric analysis. Arch Osteoporos 16(1):73CrossRefPubMed Wu H, Li Y, Tong L, Wang Y, Sun Z (2021) Worldwide research tendency and hotspots on hip fracture: a 20-year bibliometric analysis. Arch Osteoporos 16(1):73CrossRefPubMed
12.
go back to reference Yeung AWK, Tzvetkov NT, Balacheva AA, Georgieva MG, Gan RY, Jozwik AP et al (2020) Lignans: quantitative analysis of the research literature. Front Pharmacol 11:37CrossRefPubMedPubMedCentral Yeung AWK, Tzvetkov NT, Balacheva AA, Georgieva MG, Gan RY, Jozwik AP et al (2020) Lignans: quantitative analysis of the research literature. Front Pharmacol 11:37CrossRefPubMedPubMedCentral
13.
go back to reference Van Eck NJ, Waltman L (2009) Vosviewer, a computer program for bibliometric mapping. In: Proceedings of ISSI 2009—12th international conference of the international society for scientometrics and informetrics, vol 22, pp 886–897 Van Eck NJ, Waltman L (2009) Vosviewer, a computer program for bibliometric mapping. In: Proceedings of ISSI 2009—12th international conference of the international society for scientometrics and informetrics, vol 22, pp 886–897
14.
15.
go back to reference Synnestvedt MB, Chen C, Holmes JH (2005) CiteSpace II: visualization and knowledge discovery in bibliographic databases. AMIA Annu Symp Proc 2005:724–728PubMedPubMedCentral Synnestvedt MB, Chen C, Holmes JH (2005) CiteSpace II: visualization and knowledge discovery in bibliographic databases. AMIA Annu Symp Proc 2005:724–728PubMedPubMedCentral
16.
go back to reference Sabe M, Pillinger T, Kaiser S et al (2022) Half a century of research on antipsychotics and schizophrenia: a scientometric study of hotspots, nodes, bursts, and trends. Neurosci Biobehav Rev 136:104608CrossRefPubMed Sabe M, Pillinger T, Kaiser S et al (2022) Half a century of research on antipsychotics and schizophrenia: a scientometric study of hotspots, nodes, bursts, and trends. Neurosci Biobehav Rev 136:104608CrossRefPubMed
17.
go back to reference Hsu SI, Ramirez SB, Winn MP, Bonventre JV, Owen WF (2000) Evidence for genetic factors in the development and progression of IgA nephropathy. Kidney Int 57(5):1818–1835CrossRefPubMed Hsu SI, Ramirez SB, Winn MP, Bonventre JV, Owen WF (2000) Evidence for genetic factors in the development and progression of IgA nephropathy. Kidney Int 57(5):1818–1835CrossRefPubMed
18.
go back to reference Yeo SC, Goh SM, Barratt J (2019) Is immunoglobulin A nephropathy different in different ethnic populations? Nephrology (Carlton) 24(9):885–895CrossRefPubMed Yeo SC, Goh SM, Barratt J (2019) Is immunoglobulin A nephropathy different in different ethnic populations? Nephrology (Carlton) 24(9):885–895CrossRefPubMed
20.
go back to reference Barratt J, Lafayette R, Kristensen J et al (2023) Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy. Kidney Int 103(2):391–402CrossRefPubMed Barratt J, Lafayette R, Kristensen J et al (2023) Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy. Kidney Int 103(2):391–402CrossRefPubMed
21.
go back to reference He JW, Zhou XJ, Lv JC, Zhang H (2020) Perspectives on how mucosal immune responses, infections and gut microbiome shape IgA nephropathy and future therapies. Theranostics 10(25):11462–11478CrossRefPubMedPubMedCentral He JW, Zhou XJ, Lv JC, Zhang H (2020) Perspectives on how mucosal immune responses, infections and gut microbiome shape IgA nephropathy and future therapies. Theranostics 10(25):11462–11478CrossRefPubMedPubMedCentral
22.
go back to reference Tan J, Dong L, Jiang Z et al (2022) Probiotics ameliorate IgA nephropathy by improving gut dysbiosis and blunting NLRP3 signaling. J Transl Med 20(1):382CrossRefPubMedPubMedCentral Tan J, Dong L, Jiang Z et al (2022) Probiotics ameliorate IgA nephropathy by improving gut dysbiosis and blunting NLRP3 signaling. J Transl Med 20(1):382CrossRefPubMedPubMedCentral
23.
go back to reference Lauriero G, Abbad L, Vacca M et al (2021) Fecal microbiota transplantation modulates renal phenotype in the humanized mouse model of IgA nephropathy. Front Immunol 12:694787CrossRefPubMedPubMedCentral Lauriero G, Abbad L, Vacca M et al (2021) Fecal microbiota transplantation modulates renal phenotype in the humanized mouse model of IgA nephropathy. Front Immunol 12:694787CrossRefPubMedPubMedCentral
24.
go back to reference Zhao J, Bai M, Yang X, Wang Y, Li R, Sun S (2021) Alleviation of refractory IgA nephropathy by intensive fecal microbiota transplantation: the first case reports. Ren Fail 43(1):928–933CrossRefPubMedPubMedCentral Zhao J, Bai M, Yang X, Wang Y, Li R, Sun S (2021) Alleviation of refractory IgA nephropathy by intensive fecal microbiota transplantation: the first case reports. Ren Fail 43(1):928–933CrossRefPubMedPubMedCentral
25.
go back to reference Zhi W, Song W, Abdi Saed Y, Wang Y, Li Y (2022) Fecal capsule as a therapeutic strategy in IgA nephropathy: a brief report. Front Med (Lausanne) 9:914250CrossRefPubMed Zhi W, Song W, Abdi Saed Y, Wang Y, Li Y (2022) Fecal capsule as a therapeutic strategy in IgA nephropathy: a brief report. Front Med (Lausanne) 9:914250CrossRefPubMed
26.
go back to reference Coppo R, Amore A, Roccatello D (1992) Dietary antigens and primary immunoglobulin A nephropathy. J Am Soc Nephrol 2(10 Suppl):S173–S180CrossRefPubMed Coppo R, Amore A, Roccatello D (1992) Dietary antigens and primary immunoglobulin A nephropathy. J Am Soc Nephrol 2(10 Suppl):S173–S180CrossRefPubMed
27.
go back to reference Papista C, Lechner S, Ben Mkaddem S et al (2015) Gluten exacerbates IgA nephropathy in humanized mice through gliadin-CD89 interaction. Kidney Int 88(2):276–285CrossRefPubMed Papista C, Lechner S, Ben Mkaddem S et al (2015) Gluten exacerbates IgA nephropathy in humanized mice through gliadin-CD89 interaction. Kidney Int 88(2):276–285CrossRefPubMed
Metadata
Title
Global trends and hotspots in IgA nephropathy: a bibliometric analysis and knowledge map visualization from 2012 to 2023
Authors
Jingyu Wang
Xin Wang
Xintian Cai
Dikang Pan
Publication date
19-04-2023
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 12/2023
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-023-03598-x

Other articles of this Issue 12/2023

International Urology and Nephrology 12/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.